Search hospitals > Pennsylvania > Wynnewood

Lankenau Medical Center

Claim this profile
Wynnewood, Pennsylvania 19096
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
346 reported clinical trials
22 medical researchers
Photo of Lankenau Medical Center in WynnewoodPhoto of Lankenau Medical Center in WynnewoodPhoto of Lankenau Medical Center in Wynnewood

Summary

Lankenau Medical Center is a medical facility located in Wynnewood, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Lankenau Medical Center is involved with conducting 346 clinical trials across 384 conditions. There are 22 research doctors associated with this hospital, such as Albert DeNittis, MD, Paul B. Gilman, William Gray, MD, and Basel Ramlawi, MD.

Area of expertise

1Cancer
Global Leader
Lankenau Medical Center has run 93 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Lankenau Medical Center has run 58 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Lankenau Medical Center

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Ovarian Cancer
Pancreatic Cancer
Fallopian Tube Cancer
Small Cell Lung Cancer
Follicular Lymphoma
Endometrial Cancer
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Lankenau Medical Center?
Lankenau Medical Center is a medical facility located in Wynnewood, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Lankenau Medical Center is involved with conducting 346 clinical trials across 384 conditions. There are 22 research doctors associated with this hospital, such as Albert DeNittis, MD, Paul B. Gilman, William Gray, MD, and Basel Ramlawi, MD.
Where is Lankenau Medical Center located?
To reach Lankenau Medical Center in Wynnewood, Pennsylvania: 1. Take I-95 to I-676/76 West in Philadelphia. 2. Exit onto City Avenue and head south on Route 1 (City Line Avenue) to the intersection of Route 30 (Lancaster Avenue). 3. Turn right onto Lancaster Avenue; the hospital will be on your left. Alternatively, utilize GPS navigation services like Waze for real-time directions.
Who should I call to ask about financial aid or insurance network?
**Lankenau Medical Center Financial Assistance:** - Contact the Main Line Health Business office at 484.337.1970 for financial assistance inquiries. - Financial assistance is available based on annual income and household size, with 100% assistance for those with income 300% or less of the federal poverty guidelines, and significant discounts for those with income between 300% and 500%. - Financial counselors are available to assist with the application process. **NYU Langone Health Insurance Information:** - Visit the NYU Langone Health website for detailed information on insurance, billing, and financial assistance. - It's recommended to consult with your insurance company for accurate out-of-pocket costs for services at NYU Langone. - In emergency situations or when treated by an out-of-network provider at an in-network hospital, you're protected from being charged beyond your plan’s copayments, coinsurance, or deductible.
What insurance does Lankenau Medical Center accept?
Lankenau Medical Center, part of Main Line Health, accepts a broad spectrum of health insurance plans. This includes commercial plans such as Aetna, Cigna, Capital Blue Cross, Highmark Blue Shield, Independence Blue Cross, and United Healthcare. They also welcome Medicare Advantage plans like Advantra Medicare (Aetna), Humana Medicare Advantage, and USA MCO, in addition to Medicaid MCO plans such as AmeriHealth Caritas and PA Health and Wellness.
What awards or recognition has Lankenau Medical Center received?
Lankenau Medical Center has been awarded a Silver Milestone recognition by the Intersocietal Accreditation Commission (IAC) for 25 years of IAC Echocardiography accreditation. It was also ranked No. 168 in Newsweek's list of the nation's best hospitals, recognized for attracting top talent, delivering excellent patient outcomes, and pioneering advanced therapies and research.